TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MGROF Stock 12 Month Forecast
Average Price Target
―
Based on 1 Wall Street analysts offering 12 month price targets for MustGrow Biologics in the last 3 months. The average price target is ― with a high forecast of ― and a low forecast of ―. The average price target represents a ― change from the last price of $0.41.
Find stocks in the Basic Materials sector that are highly recommended by Top Performing Analysts.
MGROF Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Sep 25
Dec 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
4
4
4
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
4
3
3
In the current month, MGROF has received 0Buy Ratings, 3Hold Ratings, and 0Sell Ratings. MGROF average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
MGROF Financial Forecast
MGROF Earnings Forecast
The previous quarter’s earnings for MGROF were -$0.03.
The previous quarter’s earnings for MGROF were -$0.03.
MGROF Sales Forecast
The previous quarter’s earnings for MGROF were $572.78K.
The previous quarter’s earnings for MGROF were $572.78K.
MGROF Stock Forecast FAQ
What is MGROF’s average 12-month price target, according to analysts?
Currently, no data Available
What is MGROF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MGROF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MGROF a Buy, Sell or Hold?
MustGrow Biologics has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is MustGrow Biologics’s price target?
Currently, no data Available
What do analysts say about MustGrow Biologics?
MustGrow Biologics’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of MGROF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.